Jay joins us a PhD student under IOB's MD-PhD program. Jay Zoellin's research project aims to address a critical gap in current medical care: Researchers at IOB recently discovered that a previously overlooked mutation is potentially the most common genetic defect in inherited retinal diseases. However, despite the high prevalence of this condition, both disease models and therapeutic options for affected individuals are still missing. Zoellin's project involves establishing models that accurately recapitulates the disease's pathogenesis and leveraging advanced gene therapy techniques to address this gap and develop an effective treatment.
Jay received the prestigious SAMW National MD-PhD grant (https://www.samw.ch/en/Funding/MD-PhD-Program.html). Congratulations!
Comments